ANTIDIABETIC AND ADAPTOGENIC PROPERTIES OF MOMORDICA-CHARANTIA EXTRACT - AN EXPERIMENTAL AND CLINICAL-EVALUATION

被引:103
作者
SRIVASTAVA, Y
VENKATAKRISHNABHATT, H
VERMA, Y
VENKAIAH, K
RAVAL, BH
机构
[1] ALKANAND AYURVED COLL,AHMEDABAD,GUJARAT,INDIA
[2] NATL INST OCCUPAT HLTH,AHMEDABAD 380016,INDIA
关键词
MOMORDICA-CHARANTIA (BITTER GOURD) EXTRACT; HYPOGLYCEMIA; CATARACT (SECONDARY COMPLICATION OF DIABETES); CLINICAL EVALUATION;
D O I
10.1002/ptr.2650070405
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The hypoglycaemic properties of Mormodica charantia (bitter gourd) water extract was tested on alloxan diabetic rats experimentally. A fall of blood sugar after 3 week's treatment with aqueous extract of fruits of the herb was found to be significant (P<0.01). The aqueous extract was more effective in diabetes (fall of blood sugar 54% after 3 week's therapy) than the powder of the dried fruit (fall 25% nonsignificant). Hypoglycaemic effects in diabetic patients were found to be highly significant (p<0.01) at the end of the trial but were cumulative and gradual, unlike that produced by insulin. Adaptogenic properties are indicated by the delay in the appearance of cataracts, the secondary complications of diabetes and relief in neurological and other common symptoms even before the hypoglycaemia occurred.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 33 条
  • [1] CLINICAL-TRIAL IN PATIENTS WITH DIABETES-MELLITUS OF AN INSULIN-LIKE COMPOUND OBTAINED FROM PLANT SOURCE
    BALDWA, VS
    BHANDARI, CM
    PANGARIA, A
    GOYAL, RK
    [J]. UPSALA JOURNAL OF MEDICAL SCIENCES, 1977, 82 (01) : 39 - 41
  • [2] GLYCOSYLATION OF HEMOGLOBIN - RELEVANCE TO DIABETES-MELLITUS
    BUNN, HF
    GABBAY, KH
    GALLOP, PM
    [J]. SCIENCE, 1978, 200 (4337) : 21 - 27
  • [3] CERAMI A, 1979, METABOLISM, V28, P431, DOI 10.1016/0026-0495(79)90051-9
  • [4] CHANG AT, 1979, DIABETES, V28, P408
  • [5] Chopra RN, 1958, INDIGENOUS DRUGS IND, p[597, 672]
  • [6] RELATIONSHIP OF MICROVASCULAR DISEASE IN DIABETES TO METABOLIC CONTROL
    ENGERMAN, R
    BLOODWORTH, JMB
    NELSON, S
    [J]. DIABETES, 1977, 26 (08) : 760 - 769
  • [7] FISCHER RW, 1980, CLIN LAB HAEMATOL, V2, P129
  • [8] GUPTA SS, 1978, J MED ASSN, V39, P581
  • [9] JOB D, 1975, DIABETES DIAEAZ S2, V24, P393
  • [10] KHANNA P, 1985, E PHARM, P101